Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Evaluation of the Correlation Between the MS Functional Composite Index and Two Quality of Life Scales (MS54 and AMS Quality of Life) in Relapsing MS Patients Treated With Interferon Beta-1a (AVONEX®)

NCT00534261 is registered in ClinicalTrials.gov with Biogen as lead sponsor.

NCT NCT00534261
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT00534261 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Evaluation of the Correlation Between the MS Functional Composite Index and Two Quality of Life Scales (MS54 and AMS Quality of Life) in Relapsing MS Patients Treated With Interferon Beta-1a (AVONEX®)
Lead sponsor
Biogen
Phase
Phase 4
Overall status
Completed
Start date
November 30, 1999
Completion date
February 29, 2004
Enrollment
284 (actual)
Sites
3

Conditions

As the registry lists them; a condition with its own page is linked.

relapsing remitting multiple sclerosis